IBJNews

Report: State's pharmaceutical contractors continue to grow

Back to TopCommentsE-mailPrintBookmark and Share

Indiana companies providing contract pharmaceutical research and manufacturing services continued to grow last year despite the severe economic challenges, according to a report set to be released Wednesday by BioCrossroads.

The life sciences industry group cited such Indianapolis companies as AIT Laboratories and BioStorage Technologies, as well as Bloomington-based BioConvergence, as examples of the growth.

A drive within the pharmaceutical and biotechnology industries to lower costs by outsourcing work to contract service providers is driving much of the expansion, the report said.

“We believe the outlook for the biopharma contract service sector continues to be positive, particularly for Indiana’s pharmaceutical development and contract manufacturing companies,” BioCrossroads CEO David Johnson said in a prepared statement.

The report said the demand for contract service providers should continue to increase as the need for more clinical trials and biomarker services escalates. However, the report cautioned that consolidation within the pharmaceutical industry also could force contractors to find new revenue sources.

More than 40 companies considered contract service providers are located in Indiana. Altogether, they employ about 9,000 people, the report said.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT